Literature DB >> 11956075

Significant increase of colonic mutated crypts in ulcerative colitis correlatively with duration of illness.

Isao Okayasu1, Kiyomi Hana, Tsutomu Yoshida, Tetuo Mikami, Jun Kanno, Mutsunori Fujiwara.   

Abstract

Mild periodic acid-Schiff (mPAS) staining can discriminate non-O-acetylated(mPAS positive) from O-acetylated (mPAS negative) epithelial sialoglycoproteins in human colonic mucosa, giving three haplotypes of expression of a single polymorphic autosomal gene (oat). Increase in mPAS-positive crypts in heterozygotes is an indication of mutations, and wholly mPAS-positive (stem cell mutated) crypts and clusters of two or more mPAS-positive crypts in heterozygotes of ulcerative colitis (P < 0.0001) were found to be increased significantly, compared with controls. The observed correlation with ulcerative colitis duration (r = 0.892 and 0.853, respectively) supports a chronic inflammation-carcinoma sequence.

Entities:  

Mesh:

Year:  2002        PMID: 11956075

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.

Authors:  K Ishiguro; T Yoshida; H Yagishita; Y Numata; T Okayasu
Journal:  Gut       Date:  2005-12-14       Impact factor: 23.059

2.  Appearance of epithelial and stromal genomic instability in background colorectal mucosa of sporadic colorectal cancer patients: relation to age and gender.

Authors:  Harue Umeto; Tsutomu Yoshida; Kayo Araki; Hiroko Yagishita; Tetuo Mikami; Isao Okayasu
Journal:  J Gastroenterol       Date:  2009-07-11       Impact factor: 7.527

3.  Peroxiredoxin 1 expression in active ulcerative colitis mucosa identified by proteome analysis and involvement of thioredoxin based on immunohistochemistry.

Authors:  Kayo Horie; Tetuo Mikami; Tsutomu Yoshida; Yuichi Sato; Isao Okayasu
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

4.  High expression of HSP47 in ulcerative colitis-associated carcinomas: proteomic approach.

Authors:  K Araki; T Mikami; T Yoshida; M Kikuchi; Y Sato; M Oh-ishi; Y Kodera; T Maeda; I Okayasu
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.